Abstract
Market Intelligence Report
The complete report provides an invaluable mix of vital market data and
background information, including five-year market projections. The report
comprises four main sections: Pharmaceutical Market Outlook, Background Data,
Healthcare System, and Accessing the Pharmaceutical Market. Report sections
are dynamically updated, being re-issued when market developments demand it.
Pharmaceutical Market Outlook
An integral part of the full report, the Pharmaceutical Market Outlook, which
includes five-year market projections, is also available separately.
The Indian pharmaceutical market is about to enter a new era, with the
recognition under the TRIPs (Trade-Related aspects of Intellectual Property
Rights) agreement of pharmaceutical product patents from 1st January 2005.
This change undoubtedly makes the market a more attractive proposition to
international companies, although entry into a market traditionally served by
a vast, albeit fragmented domestic industry is likely to be extremely
competitive. The market leaders are the big domestic firms: Ranbaxy, Dr.
Reddy's and Cipla, among others, although no one company has a market share of
more than 5%. In 2004, there are only three multinationals with a significant
presence on the Indian market: GSK, Pfizer and Aventis.
As the Indian economy develops, more people move into the growing middle
classes and gain disposable income. Alongside this is an increasing demand for
high quality healthcare. Espicom's Market Intelligence Report sets the
pharmaceutical market into context, providing background information on the
country, its people and the organisation of its healthcare services, including
information on the main private healthcare providers.
Inside the India Market Intelligence Report
- Key information is provided on the regulatory environment, including the
pharmaceutical policy, pharmaceutical registration, advertising,
pharmaceutical patent protection and exclusive marketing right, and pricing
regulation;
- Distribution channels, trade fairs, pharmaceutical import data for 45
categories for 1998-2002;
- Domestic production, including data on global sales by leading domestic
companies for 2003/04 and a review of the trade associations and leading
producers. Information is included on these domestic manufacturers: Alembic,
Aurobindo Pharma, BCG Vaccine Laboratory, Biocon, Blue Cross Laboratories
Cipla, Dr Reddy's, Lupin, Nicholas Piramal, Orchid, Ranbaxy, Sun Pharma,
WocKhardt and Zydus Cadila as well as the Indian operations of Aventis Pharma,
GlaxoSmithKline and Pfizer;
- The current size of the market, five year market projections to 2009, the
market outlook, the structure of the pharmaceutical market and recent market
developments, such as the domestic companies involved with the WHO
prequalification list for antiretroviral drugs;
- Research and development, Traditional Indian medicines, pharmaceutical
exports, contact information for government healthcare organisations and trade
association;
- Political and economic overviews;
- Key data on the population, demographic indicators, mortality data, trends
in morbidity and a review of the government's major health projects;
- Information on India's healthcare infrastructure, including hospitals and
ambulatory care, medical personnel and health expenditure.
View Cart
